Stock listing

Xetra:0QF Moderna, Inc. Aktie

German listing (Xetra) of Moderna, Inc. · home listing NASDAQ:MRNA

Follow Moderna, Inc. into a list and get an email when it puts out news.

Share price · XETR:0QF

€175.90 EUR -4.70 (-2.6%)

Close on Oct 27, 2026

Day range
€161.76 – €177.56 EUROct 27, 2026
Volume
45,196 sharesOct 27, 2026
Market cap
€70.23B EURAt the close on Oct 27, 2026 · price × 399.2M shares outstanding
Moderna, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MRNA · Home$221.72 USD-1.04 (-0.5%)8,988,811$221.11$227.53$217.22$222.76Close on Oct 30, 2026
Xetra:0QF€175.90 EUR-4.70 (-2.6%)45,196€175.34€177.56€161.76€180.60Close on Oct 27, 2026
B3:M1RN3455.82 BRL+6.32 (+12.8%)186,41251.4055.8247.7549.50Close on Oct 27, 2026
Frankfurt:0QF€196.00 EUR+9.14 (+4.9%)373€199.00€202.00€196.00€186.86Close on Oct 30, 2026
Ticker
Xetra:0QF
Asset type
Stock
Exchange
Xetra
Currency
EUR

What changed lately

Calls

Upcoming

  • Moderna (NASDAQ:MRNA) Q3 2026 Earnings Call

    Fri, Nov 06, 2026 · 8:00 AM ET

    Register

Replays

  • Moderna (NASDAQ:MRNA) Q2 2026 Earnings Call

    Fri, Jul 31, 2026 · 8:00 AM ET

    Watch Transcript

  • Moderna (NASDAQ:MRNA) Q1 2026 Earnings Call

    Fri, May 01, 2026 · 8:00 AM ET

    Watch Transcript

  • Moderna (NASDAQ:MRNA) Q4 2025 Earnings Call

    Fri, Feb 13, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

Moderna Named a Top Employer by Science for Twelfth Consecutive Year

Oct 23, 2026

Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium

Oct 22, 2026

Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026

Oct 13, 2026

Moderna Adds Chief Operating Officer Role as Company Expands into Oncology

Sep 30, 2026

Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026

Sep 21, 2026

Moderna to Present at Upcoming Conferences in September 2026

Sep 1, 2026

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Aug 28, 2026

Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines

Aug 27, 2026

Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes

Aug 27, 2026

Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

Aug 5, 2026

All Moderna, Inc. news

Financings

  • 0.00% Convertible Senior Notes due 2032

    Aug 28, 2026

    Made bigger: US$2.6B

    Use of proceeds: Pay about $285.0 million for capped call transactions and general corporate purposes, possibly including growing the oncology business and repaying debt

    Announced Aug 27, 2026 · Made bigger Aug 28, 2026

Read by 6ix AI from the company's releases

Decks

Moderna, Inc. on 6ix

News releases
57 in the last 12 months · 391 in all · newest Oct 23, 2026 · oldest 2021
Calls
25 calls with a replay · 25 with a transcript · latest Jul 31, 2026
Decks
63 decks · latest Jul 31, 2026

Where Moderna, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MRNA · Home listingNASDAQUnited StatesUSD
gettex:0QFgettexGermanyEUR
Milan:1MRNAMilanItalyEUR
Xetra:0QF · This pageXetraGermanyEUR
Tradegate:0QFTradegateGermanyEUR
BCBA:MRNABCBAArgentinaARS
LS Exchange:A2N9D9LS ExchangeGermanyEUR
BMV:MRNABMVMexicoMXN
B3:M1RN34B3BrazilBRL
BOATS:MRNABOATSUnited StatesUSD
EUROTLX:4MRNAEUROTLXItalyEUR
Lang & Schwarz:A2N9D9Lang & SchwarzGermanyEUR
LSIN:0A45LSINUnited KingdomUSD
BIVA:MRNABIVAMexicoMXN
BCBA:MRNADBCBAArgentinaUSD
Stuttgart:0QFStuttgartGermanyEUR
Frankfurt:0QFFrankfurtGermanyEUR
Aquis:0QFDAquisUnited KingdomEUR
SIX Swiss:MRNASIX SwissSwitzerlandCHF
Munich:0QFMunichGermanyEUR
VIE:MRNAViennaAustriaEUR
SIX Swiss:MRNA.USDSIX SwissSwitzerlandUSD
BCBA:MRNACBCBAArgentinaUSD
Dusseldorf:0QFDusseldorfGermanyEUR
BX Swiss:0QFBX SwissSwitzerlandCHF
Hamburg:0QFHamburgGermanyEUR
BSESOF:0QFBSESOFBulgariaEUR
BVL:MRNAUSBVLPeruPEN
Hanover:0QFHanoverGermanyEUR
Turquoise:MRNANTurquoiseUnited KingdomUSD
Aquis:0QFDAquisUnited KingdomEUR
BCBA:MRNA.CIBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Moderna, Inc.